Ischemic optic neuropathy with semaglutide: global observational analysis of sex- and formulation-specific risk.

چکیده

Ischaemic optic neuropathy (ION) is a rare but vision-threatening complication recently linked to GLP-1 receptor agonists, particularly semaglutide. Using over 30 million reports from the FDA Adverse Event Reporting System (2017-2024), we evaluated formulation- and sex-specific associations. Among…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط